Norwegian Study Shifts Support Toward Biosimilar Switching
October 17, 2016
A new study abstract released today in Norway demonstrates support for switching patients from an branded biologic to a biosimilar […]
Sandoz Inc. v. Amgen Inc. at the Supreme Court: Expediting Access to Affordable Biosimilars
June 16, 2017
From the Association for Accessible Medicines and the Biosimilars Council: Introduction: The Association for Accessible Medicines (AAM) applauds the U.S. […]
